Sam Brusco, Associate Editor01.10.22
Owens & Minor and Apria have entered an agreement for Owens & Minor to acquire Apria for a total transaction value of $1.6 billion.
“I’m very excited about the acquisition of Apria, which will strengthen our total company value proposition,” Edward A. Pesicka, president and CEO of Owens & Minor told the press. “The combination of two complementary businesses in Byram Healthcare and Apria will enable us to better serve the entire patient journey - through the hospital and into the home—ultimately furthering our mission of Empowering Our Customers to Advance Healthcare. In addition, this transaction diversifies our total company revenue stream by expanding our presence in the higher-growth home healthcare market.”
Pesicka added, “We are impressed by what Apria has built for its customers, and I look forward to welcoming Dan Starck and the Apria team to Owens & Minor upon close.”
“I am energized and enthusiastic to join Owens & Minor,” said Dan Starck, CEO of Apria. “Both companies share cultures fueled by a commitment to customers, patients, teammates and the communities we serve. We look forward to joining together and delivering the highest quality healthcare solutions to our customers.”
The acquisition positions Owens & Minor as a leader in the home healthcare market. It expands the company’s Patient Direct platform with access to over 90 percent of insured U.S. healthcare customers.
Owens & Minor gains a portfolio in home respiratory, obstructive sleep apnea, and negative pressure wound therapy. These are highly complementary to the company’s existing diabetes, ostomy, incontinence, and wound care portfolio.
“I’m very excited about the acquisition of Apria, which will strengthen our total company value proposition,” Edward A. Pesicka, president and CEO of Owens & Minor told the press. “The combination of two complementary businesses in Byram Healthcare and Apria will enable us to better serve the entire patient journey - through the hospital and into the home—ultimately furthering our mission of Empowering Our Customers to Advance Healthcare. In addition, this transaction diversifies our total company revenue stream by expanding our presence in the higher-growth home healthcare market.”
Pesicka added, “We are impressed by what Apria has built for its customers, and I look forward to welcoming Dan Starck and the Apria team to Owens & Minor upon close.”
“I am energized and enthusiastic to join Owens & Minor,” said Dan Starck, CEO of Apria. “Both companies share cultures fueled by a commitment to customers, patients, teammates and the communities we serve. We look forward to joining together and delivering the highest quality healthcare solutions to our customers.”
The acquisition positions Owens & Minor as a leader in the home healthcare market. It expands the company’s Patient Direct platform with access to over 90 percent of insured U.S. healthcare customers.
Owens & Minor gains a portfolio in home respiratory, obstructive sleep apnea, and negative pressure wound therapy. These are highly complementary to the company’s existing diabetes, ostomy, incontinence, and wound care portfolio.